| 1. | 3doctors | |
| 2. | eviltaskmaster | |
| 3. | beachgirlxoxo | |
| 4. | oneltonfan | |
| 5. | missygayle |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | beachgirlxoxo 01/29/2018 Goldman Sachs initiates as a sell, $32PT |
| 2. | oneltonfan 05/08/2018 Sees FY18 EPS of $1.19-1.21 |
| 3. | beachgirlxoxo 02/08/2018 Myriad's myRisk® Hereditary Cancer Test Finds More Than 12 Percent of Men with Prostate Cancer Carry an Inherited Genetic Mutation |
| 4. | 3doctors 05/08/2018 up 15.77%. |
| 5. | oneltonfan 05/08/2018 Yes ahah |
| 6. | beachgirlxoxo 06/21/2018 Top-Five National Payer Issues Positive Coverage Decision for Myriad's Prolaris® Test for Prostate Cancer |
| 7. | eviltaskmaster 05/08/2018 I am seeing $40s |
| 8. | beachgirlxoxo 02/06/2018 Beats EPS estimates by $0.07 and beats on revenues |
| 9. | beachgirlxoxo 01/15/2018 Awesome news |
| 10. | oneltonfan 02/21/2018 NCCN Guidelines Broadly Endorse Biomarker Testing in Prostate Cancer |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Myriad Genetics, Inc.
- MYGN
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.